Papers › Target Specific De Novo Design of Drug Candidate Molecules with Graph...

Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks

15 Feb 2023arXiv:2302.07868archive 2025-07-28

Atabey Ünlü, Elif Çevrim, Melih Gökay Yiğit, Ahmet Sarıgün, Hayriye Çelikbilek, Osman Bayram, Deniz Cansen Kahraman, Abdurrahman Olğaç, Ahmet Sureyya Rifaioğlu, Erden Banoğlu, Tunca Doğan

Discovering novel drug candidate molecules is one of the most fundamental and critical steps in drug development. Generative deep learning models, which create synthetic data given a probability distribution, offer a high potential for designing de novo molecules. However, to be utilisable in real life drug development pipelines, these models should be able to design drug like and target centric molecules. In this study, we propose an end to end generative system, DrugGEN, for the de novo design of drug candidate molecules that interact with intended target proteins. The proposed method represents molecules as graphs and processes them via a generative adversarial network comprising graph transformer layers. The system is trained using a large dataset of drug like compounds and target specific bioactive molecules to design effective inhibitory molecules against the AKT1 protein, which is critically important in developing treatments for various types of cancer. We conducted molecular docking and dynamics to assess the target centric generation performance of the model, as well as attention score visualisation to examine model interpretability. In parallel, selected compounds were chemically synthesised and evaluated in the context of in vitro enzymatic assays, which identified two bioactive molecules that inhibited AKT1 at low micromolar concentrations. These results indicate that DrugGEN's de novo molecules have a high potential for interacting with the AKT1 protein at the level of its native ligands. Using the open access DrugGEN codebase, it is possible to easily train models for other druggable proteins, given a dataset of experimentally known bioactive molecules.

PaperPDFCode

Syntology This paper's arXiv id is not in Syntology's Atlas id list (549,449 ids, as this build read them; the read time is in the build record), so this page links to no Syntology page for it. The list is not the whole graph; Syntology's feed shows papers as they enter the graph.

Code

hubiodatalab/druggen officialmentioned in papermentioned on GitHubpytorchSyntology: no sample linked to this paper (harvested for another paper). Syntology's graph links these samples to Attention Is All You Need (arXiv:1706.03762; that paper's own run record: 610 ran (of which 293 constructed an object rather than computing a result; 529 with no instrument failure: 45 honoured, 15 violated, 469 with no contract checked; 81 where Syntology's instrument failed) · 336 unverified); nothing checks that they implement this paper's method. report
asarigun/DrugGEN officialmentioned on GitHubpytorchSyntology: not harvested report

Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.

A paper named beside a repository with no sample linked to this paper is shown with that paper's own run record, not this paper's: “ran” means executed on a synthesized input, not that the code is correct, and “where Syntology's instrument failed” counts failures of Syntology's instrument, not of the code. Papers are listed in arXiv-id order, at most three per repository.

Code Syntology ran Syntology

Not run by Syntology. Nothing on this page verifies that the listed code works.

Tasks

Molecular Graph Generation

1 archive task tag without a task page not shown.

Results from the paper archive 2025-07-28

No leaderboard rows for this paper in the archive.

Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections